The FDA has approved Saphnelo (anifrolumab-fnia) for subcutaneous administration in patients with systemic lupus erythematosus.
Ocular Therapeutix has initiated a long-term extension trial evaluating the investigational intravitreal therapy AXPAXLI in ...
Rusfertide may reduce phlebotomy needs in polycythemia vera, offering a convenient weekly self-injection option that could ...
PUSH provides allergy injection services for all eligible students who have a referral from their allergist. Prior to receiving allergy injections at PUSH, patients need to meet with their allergist ...
A new white paper entitled "Inside the Science: A Major Step Forward for Knee Osteoarthritis" has been released which heralds the dawn of a new era of treatments for knee osteoarthritis (OA) that can ...
NEEDHAM, Mass., Oct. 9, 2025 /PRNewswire/ -- Stealth BioTherapeutics Inc. (the "Company" or "Stealth"), a commercial-stage biotechnology company focused on the discovery, development and ...
The Louisiana Department of Public Health (LDH) is reminding the public to take precautions before receiving injections of botulinum toxin, commonly referred to as botox, and to avoid receiving ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results